Jiangxi Fushine Pharmaceutical Co., Ltd., Jingdezhen, China – FDA Inspections

Inspection records and compliance data for Jiangxi Fushine Pharmaceutical Co., Ltd. in Jingdezhen. 3 FDA inspections on record, 1 Form 483, last inspected August 14, 2025.

Company Profile

This profile covers Jiangxi Fushine Pharmaceutical Co., Ltd. based in Jingdezhen, China.

FDA Inspection History

FDA inspections: 3
OAI: 0
VAI: 0
NAI: 2
Unclassified: 1
Form 483s: 1
Warning letters: 0

First inspected July 4, 2014. Last inspected August 14, 2025.

FDA inspections (3)

Date	Result	FDA center(s)	Insp. #
August 14, 2025	Not classified	Human Drugs	1280551
January 18, 2019	NAI	Human Drugs · Drug Quality Assurance	1084105
July 4, 2014	NAI	Human Drugs · Drug Quality Assurance	892989

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Other regulators (1)

China NMPA · 5 inspections · last March 14, 2016

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

KinOmega Biopharm Inc.

Zhejiang Better Pharmaceuticals Co., Ltd.

Tianjin Jinjin Pharmaceutical Co. Ltd.

JQC (Huayin) Pharmaceutical Co., Ltd.

Zhejiang Excel Pharmaceutical Company, Ltd.

Zhejiang Yongtai Chiral Medicine Technology Co., Ltd.

Sichuan Renan Pharmaceutical Co., Ltd

Lianhe Aigen Pharma Co, Ltd.

Topharman Shandong Co., Ltd.

Wuhan Calmland Pharmaceuticals Co., Ltd.